Bristol Myers Squibb Cell Therapy Organization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bristol Myers Squibb (BMS) has entered into an agreement with Cellares to bolster the manufacturing of chimeric antigen receptor (CAR) T cell therapies.

Lynelle hochCellares technology adoption partnershipBristol myers squibb cell therapy organizationEuropean unionCell shuttleSmart factoriesMyers squibb cell therapy organization